Merck announces over €300m investment in new bioprocessing center in South Korea
Merck has embarked on a monumental investment venture, injecting more than €300 million into the construction of a new Bioprocessing Production Center located in Daejeon, ... Read More
Gennova’s GEMCOVAC-OM Omicron-specific mRNA-based booster vaccine gets EUA in India
The Department of Biotechnology (DBT), part of the Indian Ministry of Science & Technology, has revealed that the Omicron-specific mRNA-based booster vaccine, developed by Pune-based ... Read More
Moderna, Merck get FDA breakthrough status for mRNA-4157/V940, KEYTRUDA combo in melanoma
Moderna and Merck announced that the investigational personalized mRNA cancer vaccine mRNA-4157/V940 in combination with the latter’s lung cancer drug KEYTRUDA (pembrolizumab) has been given ... Read More
Moderna, Thermo Fisher sign manufacturing agreement for Spikevax vaccine
Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as ... Read More
Moderna to build mRNA vaccine manufacturing plant in Victoria
Moderna has signed an agreement in principle with the Government of Australia to build a messenger RNA (mRNA) vaccine manufacturing plant in Victoria. According to ... Read More